XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Net Loss Per Share (Tables)
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders
The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders during the periods presented.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
Basic and diluted net loss per share:
Numerator:
Net loss attributable to common stockholders
$(1,097,015)$(15,598)$(1,023,906)$(829,927)
Denominator:
Weighted-average shares outstanding used in computing net loss per share, basic and diluted
403,212 210,768 278,409 190,058 
Net loss per share, basic and diluted
$(2.72)$(0.07)$(3.68)$(4.37)
Schedule of Weighted Average Impact of Potentially Dilutive Securities
The weighted-average impact of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive, or the issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied at the end of the respective periods, was as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
RSUs(1)
55,986 37,737 19,556 51,295 
Unvested RSAs743 155 485 307 
CEO Equity Awards(2)
32,576 19,469 10,978 20,928 
Convertible preferred stock(3)
82,891 246,355 191,032 247,327 
Stock options22,555 19,180 23,450 18,421 
Warrants88 261 202 261 
Total194,839 323,157 245,703 338,539 
__________________
(1)During the three and nine months ended September 30, 2025, RSUs excluded in the diluted per share calculations under the two class method include RSUs subject to only a service condition because the impact would be anti-dilutive. For the three and nine months ended September 30, 2024, RSUs excluded in the dilutive per share calculation include only RSUs subject to both a service and performance condition which were excluded due to RSUs being contingently issuable as of September 30, 2024.
(2)In October 2021, the Board approved a grant to the Company’s CEO of RSUs with respect to 22.5 million shares of Class B common stock. In June 2025, the Board approved a grant to the Company’s CEO of RSUs with respect to 29.0 million shares of Class B common stock. See Note 10 “Stockholders’ Equity” for further details.
(3)For the three and nine months ended September 30, 2025 and 2024 convertible preferred stock was not included in the dilutive per share calculation under the two class method, as the convertible preferred stockholders were not legally obligated to share in the Company’s losses.